Critically ill patients are at risk for a higher frequency and severity of adverse drug events (ADEs), and special patient populations of the critically ill requiring for instance individualized dosing due to non-average weight, hepatic or renal dysfunction, extracorporeal circu…
Critically ill patients are at risk for a higher frequency and severity of adverse drug events (ADEs), and special patient populations of the critically ill - requiring for instance individualized dosing due to non-average weight, hepatic or renal dysfunction, extracorporeal cir…
